Literature DB >> 17020538

The crystal structure of human dipeptidyl peptidase I (cathepsin C) in complex with the inhibitor Gly-Phe-CHN2.

Anne Mølgaard1, Jose Arnau, Conni Lauritzen, Sine Larsen, Gitte Petersen, John Pedersen.   

Abstract

hDDPI (human dipeptidyl peptidase I) is a lysosomal cysteine protease involved in zymogen activation of granule-associated proteases, including granzymes A and B from cytotoxic T-lymphocytes and natural killer cells, cathepsin G and neutrophil elastase, and mast cell tryptase and chymase. In the present paper, we provide the first crystal structure of an hDPPI-inhibitor complex. The inhibitor Gly-Phe-CHN2 (Gly-Phe-diazomethane) was co-crystallized with hDPPI and the structure was determined at 2.0 A (1 A=0.1 nm) resolution. The structure of the native enzyme was also determined to 2.05 A resolution to resolve apparent discrepancies between the complex structure and the previously published structure of the native enzyme. The new structure of the native enzyme is, within the experimental error, identical with the structure of the enzyme-inhibitor complex presented here. The inhibitor interacts with three subunits of hDPPI, and is covalently bound to Cys234 at the active site. The interaction between the totally conserved Asp1 of hDPPI and the ammonium group of the inhibitor forms an essential interaction that mimics enzyme-substrate interactions. The structure of the inhibitor complex provides an explanation of the substrate specificity of hDPPI, and gives a background for the design of new inhibitors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17020538      PMCID: PMC1770842          DOI: 10.1042/BJ20061389

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  34 in total

1.  Exploration of the P1 SAR of aldehyde cathepsin K inhibitors.

Authors:  John G Catalano; David N Deaton; Eric S Furfine; Annie M Hassell; Robert B McFadyen; Aaron B Miller; Larry R Miller; Lisa M Shewchuk; Derril H Willard; Lois L Wright
Journal:  Bioorg Med Chem Lett       Date:  2004-01-05       Impact factor: 2.823

2.  Phi/psi-chology: Ramachandran revisited.

Authors:  G J Kleywegt; T A Jones
Journal:  Structure       Date:  1996-12-15       Impact factor: 5.006

3.  Structure of human dipeptidyl peptidase I (cathepsin C): exclusion domain added to an endopeptidase framework creates the machine for activation of granular serine proteases.

Authors:  D Turk; V Janjić; I Stern; M Podobnik; D Lamba; S W Dahl; C Lauritzen; J Pedersen; V Turk; B Turk
Journal:  EMBO J       Date:  2001-12-03       Impact factor: 11.598

4.  On the size of the active site in proteases. I. Papain.

Authors:  I Schechter; A Berger
Journal:  Biochem Biophys Res Commun       Date:  1967-04-20       Impact factor: 3.575

5.  Dipeptidyl peptidase I regulates the development of collagen-induced arthritis.

Authors:  Ying Hu; Christine T N Pham
Journal:  Arthritis Rheum       Date:  2005-08

Review 6.  Lysosomal cysteine proteases (cathepsins): promising drug targets.

Authors:  Dusan Turk; Gregor Guncar
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2003-01-23

7.  Mast cell dipeptidyl peptidase I mediates survival from sepsis.

Authors:  Jon Mallen-St Clair; Christine T N Pham; S Armando Villalta; George H Caughey; Paul J Wolters
Journal:  J Clin Invest       Date:  2004-02       Impact factor: 14.808

8.  Oligomeric structure and substrate induced inhibition of human cathepsin C.

Authors:  I Dolenc; B Turk; G Pungercic; A Ritonja; V Turk
Journal:  J Biol Chem       Date:  1995-09-15       Impact factor: 5.157

9.  A Plasmodium falciparum dipeptidyl aminopeptidase I participates in vacuolar hemoglobin degradation.

Authors:  Michael Klemba; Ilya Gluzman; Daniel E Goldberg
Journal:  J Biol Chem       Date:  2004-08-10       Impact factor: 5.157

10.  Cystatin, a protein inhibitor of cysteine proteinases. Improved purification from egg white, characterization, and detection in chicken serum.

Authors:  A Anastasi; M A Brown; A A Kembhavi; M J Nicklin; C A Sayers; D C Sunter; A J Barrett
Journal:  Biochem J       Date:  1983-04-01       Impact factor: 3.857

View more
  17 in total

1.  Leukocyte cathepsin C deficiency attenuates atherosclerotic lesion progression by selective tuning of innate and adaptive immune responses.

Authors:  Veronica Herías; Erik A L Biessen; Cora Beckers; Dianne Delsing; Mengyang Liao; Mat J Daemen; Christine C T N Pham; Sylvia Heeneman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-11-13       Impact factor: 8.311

Review 2.  Neutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases.

Authors:  Brice Korkmaz; Marshall S Horwitz; Dieter E Jenne; Francis Gauthier
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

3.  Discovery of novel cyanamide-based inhibitors of cathepsin C.

Authors:  Dramane Lainé; Michael Palovich; Brent McCleland; Emilie Petitjean; Isabelle Delhom; Haibo Xie; Jianghe Deng; Guoliang Lin; Roderick Davis; Anais Jolit; Neysa Nevins; Baoguang Zhao; Jim Villa; Jessica Schneck; Patrick McDevitt; Robert Midgett; Casey Kmett; Sandra Umbrecht; Brian Peck; Alicia Bacon Davis; David Bettoun
Journal:  ACS Med Chem Lett       Date:  2010-11-10       Impact factor: 4.345

4.  Plasmodium dipeptidyl aminopeptidases as malaria transmission-blocking drug targets.

Authors:  Takeshi Q Tanaka; Edgar Deu; Alvaro Molina-Cruz; Michael J Ashburne; Omar Ali; Amreena Suri; Sandhya Kortagere; Matthew Bogyo; Kim C Williamson
Journal:  Antimicrob Agents Chemother       Date:  2013-07-08       Impact factor: 5.191

5.  Consequences of cathepsin C inactivation for membrane exposure of proteinase 3, the target antigen in autoimmune vasculitis.

Authors:  Seda Seren; Maha Rashed Abouzaid; Claudia Eulenberg-Gustavus; Josefine Hirschfeld; Hala Nasr Soliman; Uwe Jerke; Koffi N'Guessan; Sandrine Dallet-Choisy; Adam Lesner; Conni Lauritzen; Beate Schacher; Peter Eickholz; Nikoletta Nagy; Marta Szell; Cécile Croix; Marie-Claude Viaud-Massuard; Abdullah Al Farraj Aldosari; Shivanna Ragunatha; Mostafa Ibrahim Mostafa; Francesca Giampieri; Maurizio Battino; Hélène Cornillier; Gérard Lorette; Jean-Louis Stephan; Cyril Goizet; John Pedersen; Francis Gauthier; Dieter E Jenne; Sylvain Marchand-Adam; Iain L Chapple; Ralph Kettritz; Brice Korkmaz
Journal:  J Biol Chem       Date:  2018-06-20       Impact factor: 5.157

6.  Biochemical characterization of Plasmodium falciparum dipeptidyl aminopeptidase 1.

Authors:  Flora Wang; Priscilla Krai; Edgar Deu; Brittney Bibb; Conni Lauritzen; John Pedersen; Matthew Bogyo; Michael Klemba
Journal:  Mol Biochem Parasitol       Date:  2010-09-15       Impact factor: 1.759

7.  DPP1 Inhibitors: Exploring the Role of Water in the S2 Pocket of DPP1 with Substituted Pyrrolidines.

Authors:  Helena Käck; Kevin Doyle; Samantha J Hughes; Michael S Bodnarchuk; Hans Lönn; Amanda Van De Poël; Nicholas Palmer
Journal:  ACS Med Chem Lett       Date:  2019-07-15       Impact factor: 4.345

8.  Functional studies of Plasmodium falciparum dipeptidyl aminopeptidase I using small molecule inhibitors and active site probes.

Authors:  Edgar Deu; Melissa J Leyva; Victoria E Albrow; Mark J Rice; Jonathan A Ellman; Matthew Bogyo
Journal:  Chem Biol       Date:  2010-08-27

9.  Evidence for a founder mutation in the cathepsin C gene in three families with Papillon-Lefèvre syndrome.

Authors:  Mazen Kurban; Muhammad Wajid; Yutaka Shimomura; Ruba Bahhady; Abdul-Ghani Kibbi; Angela M Christiano
Journal:  Dermatology       Date:  2009-10-06       Impact factor: 5.366

10.  Papillon-Lefèvre syndrome patient reveals species-dependent requirements for neutrophil defenses.

Authors:  Ole E Sørensen; Stine N Clemmensen; Sara L Dahl; Ole Østergaard; Niels H Heegaard; Andreas Glenthøj; Finn Cilius Nielsen; Niels Borregaard
Journal:  J Clin Invest       Date:  2014-09-17       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.